Astrocytoma medical therapy

Revision as of 15:18, 11 January 2019 by Fahimeh Shojaei (talk | contribs)
Jump to navigation Jump to search

Astrocytoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Astrocytoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-Ray

Echocardiography and Ultrasound

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Study

Case #1

Astrocytoma medical therapy On the Web

Most recent articles

cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Astrocytoma medical therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Astrocytoma medical therapy

CDC on Astrocytoma medical therapy

Astrocytoma medical therapy in the news

Blogs on Astrocytoma medical therapy

Directions to Hospitals Treating Astrocytoma

Risk calculators and risk factors for Astrocytoma medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Fahimeh Shojaei, M.D.

Overview

Medical Therapy

  • Post surgical medical therapy is recommended in all patients with astrocytoma tumor.

Astrocytoma

  • 1 Grade 1 and 2 - Low grade astrocytomas
    • 1.1 Wait and see
      • The wait and see approach is for young patient with complete or nearly complete tumor resection.
      • since the low grade astrocytoma will finally grow to high grade astrocytoma, we should screen these patients with contrast MRI every 4 month.
    • 1.2 Radiation therapy
      • Immediate post surgery radiation therapy can reduce the progression rate.
      • It doesn't affect survival since it cannot prevent transformation of low grade astrocytoma to high grade astrocytoma.
      • Preferred regimen: 50 t0 54 Gy
    • 1.3 Adjunctive chemotherapy
      • 1.3.1 Temozolomide
      • 1.3.2 PVC (procarbazine, lomustine, vincristine)
      • Based on previous studies, patients who get chemotherapy along with radiotherapy immediately after surgery has better outcome.


  • 2 Grade 3 - Anaplastic astrocytoma
    • 2.1 Radiotherpay+ chemotherapy
      • Procarbazine, lomustine, vincristine
      • Procarbazine, lomustine, temozolomide


  • 3 Grade 4 - Glioblastoma multiform
    • 3.1 Chemotherapy
      • 3.1.1 Temozolomide
    • 3.2 Bevacizumab
    • 3.3 Alternating electric fields
    • 3.4 Carmustine polymer wafers

References

Template:WH Template:WS